48
USER MANUAL INFUSOVET CONNECT INFUSION PUMP
T +49 7461 96 580 0 | F +49 7461 96 580 90 | export@eickemeyer.com | www.eickemeyer.com
Guidance and manufacture’s declaration – electromagnetic immunity
The Infusion pump is intended for use in the electromagnetic environment specifi ed below. The customer or the user of
Infusion pump should assure that it is used in such an environment.
Immunity test IEC 60601 test level Compliance level
Electromagnetic environment
– guidance
Conducted RF
IEC 61000-4-6 Radiated RF
IEC 61000-4-3
3 Vrms
150 kHz to 80 MHz 3 V/m
80 MHz to 2.5 GHz
10 Vrms 10 V/m
Portable and mobile RF
communications equipment
should be used no closer to
any part of the Infusion
pump, including cables, than
the recommended separation
distance calculated from the
equation applicable to the
frequency of the transmitter.
Recommended separation
distance
d = 1.167 √P
d = 1.167 √P 80 to 800MHz
d = 2.333 √P 800 MHz to
2.5GHz
Where P is the maximum
output power rating of the
transmitter in watts (W)
according to the transmitter
manufacturer and d is the
recommended separation
distance in meters (m).
Field strengths from fi xed RF
transmitters, as determined
by an electromagnetic site
survey, a should be less than
the compliance level in each
frequency range. b
Interference may occur in the
vicinity of equipment marked
with the following symbol:
NOTE 1 At 80 MHz and 800 MHz, the higher frequency range applies.
NOTE 2 These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and
refl ection from structures, objects and people.
a
Field strengths from fi xed transmitters, such as base stations for radio (cellular / cordless) telephones and land mobile
radios, amateur radio, AM and FM radio broadcast and TV broadcast cannot be predicted theoretically with accuracy. To
assess the electromagnetic environment due to fi xed RF transmitters, an electromagnetic site survey should be considered.
If the measured fi eld strength in the location in which the Infusion pump is used exceeds the applicable RE compliance
level above the Infusion pump should be observed to verify normal operation. If abnormal performance is observed,
additional measures may be necessary, such as reorienting or relocating the Infusion pump.
b
Over the frequency range 150 kHz to 80 MHz, fi eld strengths should be less than 10 V/m.